Date | Name | Activity | Value |
---|---|---|---|
Jan 30, 2024 | Glaxosmithkline Plc >10% Owner | Bought | $16500000 |
Dec 13, 2023 | Ra Capital Management, Llc Director, >10% Owner | Bought | $5000000 |
Date | Firm | Activity | Value |
---|---|---|---|
Dec 31, 2023 | Bought | $323 | |
Dec 31, 2023 | Bought | $87324 | |
Dec 31, 2023 | Bought | $2967253 | |
Dec 31, 2023 | Bought | $3309421 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
18,202,009 | Institution | 14.89% | 88,643,784 | |
8,447,804 | Institution | 6.91% | 41,140,805 | |
3,759,408 | Institution | 3.07% | 18,308,317 | |
3,506,440 | Institution | 2.87% | 17,076,363 | |
3,317,970 | Institution | 2.71% | 16,158,514 | |
1,721,973 | Institution | 1.41% | 8,386,009 | |
1,391,561 | Institution | 1.14% | 6,776,902 | |
972,693 | Institution | 0.80% | 4,737,015 | |
660,737 | Institution | 0.54% | 3,217,789 | |
655,331 | Institution | 0.54% | 3,191,462 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
3,317,970 | Institution | 2.71% | 16,158,514 | |
972,693 | Institution | 0.80% | 4,737,015 | |
660,737 | Institution | 0.54% | 3,217,789 | |
646,018 | Institution | 0.53% | 3,146,108 | |
585,633 | Institution | 0.48% | 2,852,033 | |
231,327 | Institution | 0.19% | 1,126,562 | |
175,813 | Institution | 0.14% | 856,209 | |
169,693 | Institution | 0.14% | 826,405 | |
81,955 | Institution | 0.07% | 399,121 | |
51,548 | Institution | 0.04% | 251,039 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
1,376,466 | Institution | 1.13% | 8,492,795 | |
1,728,728 | Institution | 1.41% | 8,418,905 | |
685,932 | Institution | 0.56% | 3,340,489 | |
633,003 | Institution | 0.52% | 3,082,725 | |
273,551 | Institution | 0.22% | 1,687,810 | |
159,017 | Institution | 0.13% | 774,413 | |
108,424 | Institution | 0.09% | 521,519 | |
88,068 | Institution | 0.07% | 428,891 | |
50,262 | Institution | 0.04% | 310,117 | |
62,860 | Institution | 0.05% | 301,728 |